News | January 24, 2026
Rising demand for obesity drugs hits employer healthcare budgets, says Howden Report
The research shows 93% of global companies now cover weight-management drugs in their health insurance plans
The research shows 93% of global companies now cover weight-management drugs in their health insurance plans
Lupin’s double ‘A’ rating in Climate and Water exemplifies its steadfast commitment to sustainability
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
The partnership initially will focus on cardiovascular and kidney diseases
ALTO-207 combines pramipexole, a dopamine D3-preferring D3/D2 agonist approved for Parkinson’s disease
Myqorzo, a selective small-molecule cardiac myosin inhibitor, is designed to improve functional capacity and relieve symptoms in oHCM
The initiative is being led through the Bank’s CSR programme, Parivartan, in partnership with the Indian Cancer Society
The deal to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) underscores Bayer’s commitment to expanding in molecular imaging and advancing precision cardiology
The researchers removed a chemical group commonly used in previous NK1R drugs and replaced it with a novel molecular scaffold
The BD Neopak Glass Prefillable Syringe platform is designed for the complex needs of biologics and combination products
Subscribe To Our Newsletter & Stay Updated
